Inhalation device
Latest AstraZeneca AB Patents:
- Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer
- Combination treatment by administering a recombinant apyrase protein in conjunction with a P2Yinhibitor
- Dry powder formulation for pulmonary delivery and methods of use
- POLQ inhibitors
- ORAL FORMULATION OF A THERAPEUTIC COMPOUND
Description
FIG. 1 is a front perspective view from above and one side of an inhalation device showing our new design;
FIG. 2 is another front perspective view thereof, shown with the cap removed;
FIG. 3 is a left side elevational view thereof, of FIG. 1;
FIG. 4 is a right side elevational view thereof;
FIG. 5 is a front elevational view thereof;
FIG. 6 is a rear elevational view thereof;
FIG. 7 is a top plan view thereof; and,
FIG. 8 is a bottom plan view thereof.
Claims
The ornamental design for a inhalation device, as shown and described.
Referenced Cited
Patent History
Patent number: D515203
Type: Grant
Filed: May 3, 2004
Date of Patent: Feb 14, 2006
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Laurence Huxham (Loughborough), Darren Hodson (Loughborough), William Treneman (Dry Drayton), Nick Harrison (Oakington), Martin Bunce (Marlborough), William Davis (Marlborough)
Primary Examiner: Ian Simmons
Attorney: Fish & Richardson P.C.
Application Number: 29/204,731
Type: Grant
Filed: May 3, 2004
Date of Patent: Feb 14, 2006
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Laurence Huxham (Loughborough), Darren Hodson (Loughborough), William Treneman (Dry Drayton), Nick Harrison (Oakington), Martin Bunce (Marlborough), William Davis (Marlborough)
Primary Examiner: Ian Simmons
Attorney: Fish & Richardson P.C.
Application Number: 29/204,731
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)